The development of biologics has revolutionised medicine, enabling the treatment of previously untreatable diseases. However, the engineering of biologics remains a challenging task, requiring significant expertise and resources. Artificial intelligence (AI) and machine learning (ML) have the potential to transform biologics engineering, by enabling more efficient and accurate design, optimization, and production of proteins. For example, the ability to design and optimise antibodies with specific binding and functional properties has significant implications for a wide range of applications in medicine and biotechnology. This workshop aims to bring together researchers and practitioners from the fields of AI, ML, and biologics engineering to discuss the latest developments and future directions of this exciting interdisciplinary field. This is a follow-on from our ECML-PKDD 2023 Workshop in Turin, Italy.

Keynote Speaker: Tommi Jaakkola (MIT) Invited Talk: Ben Porbeski (University of Cambridge) Postdoc, Lab for Molecular Biology